Movers and SHAKERS
From the Blackhawks to the Biotech Industry, Daniel Carcillo Is On A Mission
The 18th annual conference will be "live" again! To celebrate the return to IN PERSON, thanks to our sponsors, investor registration is FREE
After seven recorded concussions as a result of his nine-year NHL career, Daniel Carcillo was left sleepless, plagued with migraines and at times suicidal. For years after leaving the ice, Carcillo relentlessly looked for solutions. For him and the millions who suffer from post-concussion syndrome, TBI and other mental health issues. In addition to creating a non-profit organization that assists former NHL-players with problems like his, Carcillo is the founder and CEO of Wesana Health, a life sciences company that leverages psilocybin-based medicine to treat traumatic brain injuries. Wesana recently announced that the FDA granted the Company's request for a pre-IND (Investigational New Drug) meeting to discuss the novel therapy and proprietary protocol of SANA-013 for the treatment of Traumatic Brain Injury (TBI) related major depressive disorder (MDD).
Wesana is in the lineup of companies presenting at NobleCon18, and you can hear Daniel's story as a panelist on the "Psychedelics: The Next Breakthrough in Mental Health Treatment?" Panel (Thursday, April 21, 8:00am).
ADMISSION IS FREE for institutional to self-directed novice investors, thanks to Noble, Channelchek, Sponsors and The Presenting Companies. Attendance is limited to 1,000.
NobleCon18 - Noble Capital Markets 18th Annual Small and Microcap Investor Conference - April 19-21, 2022 - Hard Rock, Hollywood, FL 100 Public Company Presentations | Scheduled Breakouts | Panel Presentations | High-Profile Keynotes | Educational Sessions | Receptions & Networking Events